
LongeVC
Europe, Ticino, Switzerland, Lugano
Description
LongeVC is an early-stage venture firm that focuses on high-impact investments in biotechnology and healthcare.
Investor Profile
LongeVC has made 18 investments, with 5 in the past 12 months and 22% as lead.
Stage Focus
- Seed (44%)
- Series A (39%)
- Series Unknown (11%)
- Pre Seed (6%)
Country Focus
- United States (67%)
- Hong Kong (6%)
- United Kingdom (6%)
- Estonia (6%)
- Switzerland (6%)
- Canada (6%)
Industry Focus
- Biotechnology
- Health Care
- Therapeutics
- Life Science
- Health Diagnostics
- Artificial Intelligence (Ai)
- Genetics
- Medical Device
- Medical
- Information Services
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.